IP Library › Patent Application 11814604
Patent Application
App. No. 11/814,604

METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/814,604
Abstract

The compounds shown by the structural formulas below have analgesic effect and are used in compositions and methods for treating mammal in need of such treatment.

Claims (52)

1 . A method of treating a mammal in need of such treatment with a pharmaceutical composition having an analgesic effect, the composition including a compound selected from the group consisting of the compounds shown by structural formulas below

or any pharmaceutically acceptable salt thereof.

2 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any pharmaceutically acceptable salt thereof.

3 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

4 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

5 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

6 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

7 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

8 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

9 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

10 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

11 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or a pharmaceutically acceptable salt of said compound.

12 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or a pharmaceutically acceptable salt of said compound.

13 . A method in accordance with claim 1 wherein the composition comprises the compound having the formula

or a pharmaceutically acceptable salt of said compound.

14 . A pharmaceutical composition of analgesic effect adapted for treating a mammal in need of such treatment, the composition including a pharmaceutically acceptable excipient and a compound selected from the group consisting of the compounds shown by structural formulas below

or any pharmaceutically acceptable salt thereof.

15 . A composition in accordance with claim 14 comprising the compound having the formula

or any pharmaceutically acceptable salt thereof.

16 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

17 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

18 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

19 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

20 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

21 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

22 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

23 . A composition in accordance with claim 14 comprising the compound having the formula

or any other pharmaceutically acceptable salt of said compound.

24 . A composition in accordance with claim 14 comprising the compound having the formula

or a pharmaceutically acceptable salt of said compound.

25 . A composition in accordance with claim 14 comprising the compound having the formula

or a pharmaceutically acceptable salt of said compound.

26 . A composition in accordance with claim 14 comprising the compound having the formula

or a pharmaceutically acceptable salt of said compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2007
From: BEAUSOLEIL, ERIC; LEBLOND, BERTRAND; TAVERNE, THIERRY; DONELLO, JOHN E.; SCHWEIGHOFFER, FABIEN
To: ALLERGAN, INC.
Reel/Frame 019619/0169 →